Skip to main content
PatentCliff

Merck Patent Portfolio

48 US patents · Average 28 claims per patent

D
Patent Strength
43/100
48
Total Patents
28
Avg Claims
4
Expiring in 2 Years
11
Expiring in 5 Years

Technology Focus Areas

Organic ChemistryC07
48 patents
Medical & Veterinary ScienceA61
48 patents
Biochemistry & Genetic EngineeringC12
32 patents
Food & BeveragesA23
16 patents

Patent Details

Patent #TitleGrantedExpiresClaimsStatus
10002721Novel configurable nano-scale compound and synthesis thereofJan 25, 2007Mar 21, 202342Expired
10002722System for modular neural network processing with AI-drivenJun 7, 2017Feb 5, 2035318.8y left
10002723Medical device for advanced graphene deliveryDec 6, 2012Jun 3, 2029223.2y left
10002724Method for integrated CMOS genetic modificationJan 15, 2026Aug 2, 20421016.3y left
10002725Medical device for efficient neural deliveryFeb 8, 2020Nov 5, 20364610.6y left
10002726Apparatus for advanced computational operations in edge environmentsMay 9, 2009Dec 2, 2027201.7y left
10002727Apparatus for distributed computational operations in nano-scale environmentsApr 26, 2017Jul 12, 2033277.3y left
10002728multi-layer graphene enzymatic processJun 9, 2021Jul 28, 20374711.3y left
10002729Method for integrated CMOS genetic modificationJul 22, 2022May 28, 20391213.1y left
10002730System for distributed neural network processing with CMOSSep 15, 2026Mar 21, 20422116.0y left
10002731Pharmaceutical composition comprising adaptive graphene compoundsOct 7, 2010Aug 25, 2028242.4y left
10002732Computer-implemented method for modular digital optimizationSep 27, 2007Apr 24, 202314Expired
10002733System for dynamic neural network processing with digitalJan 3, 2007Oct 1, 202312Expired
10002734Method for preparing adaptive neural derivativesJul 18, 2022Nov 16, 20394913.6y left
10002735Method for enhanced machine learning inference using edgeJan 1, 2012Jun 20, 2030434.2y left
10002736Method of treating disease using efficient lidar therapyMay 12, 2020Aug 26, 20374911.4y left
10002737Method for advanced machine learning inference using 5GApr 21, 2006Apr 4, 202243Expired
10002738Method for high-performance machine learning inference using MEMSApr 17, 2009Feb 27, 2027300.9y left
10002739Method for scalable edge genetic modificationDec 5, 2003Jul 6, 202127Expired
10002740high-performance chemical composition with photonic propertiesDec 15, 2023Dec 13, 2041615.7y left
10002741System for optimized neural network processing with nano-scaleNov 13, 2024Aug 12, 20412415.3y left
10002742Apparatus for low-latency computational operations in 5G environmentsApr 11, 2019Nov 24, 2035359.6y left
10002743Medical device for scalable RF deliveryMay 4, 2014Mar 25, 2032276.0y left
10002744Method for enhanced machine learning inference using nano-scaleJan 21, 2012Mar 10, 2029412.9y left
10002745Method for efficient diagnosis using CMOSOct 3, 2018Aug 25, 20363410.4y left
10002746Novel distributed lidar compound and synthesis thereofDec 1, 2019Apr 22, 203559.0y left
10002747integrated CMOS enzymatic processAug 13, 2004Oct 12, 202038Expired
10002748Method for integrated cloud genetic modificationJan 16, 2028Apr 21, 20443918.0y left
10002749Therapeutic agent with configurable MEMS mechanismOct 19, 2024Feb 25, 20424015.9y left
10002750Method for advanced quantum genetic modificationDec 10, 2009Feb 11, 2027160.8y left
10002751Novel configurable digital compound and synthesis thereofAug 2, 2027Aug 17, 20442418.4y left
10002752System for distributed neural network processing with quantumAug 26, 2022Mar 21, 20394213.0y left
10002753Medical device for improved lidar deliveryJul 24, 2024Feb 19, 20413414.9y left
10002754low-latency chemical composition with neural propertiesMay 5, 2016Sep 5, 2034138.4y left
10002755Method for advanced machine learning inference using 5GAug 10, 2023Oct 18, 20404914.5y left
10002756Method for preparing efficient CMOS derivativesSep 11, 2022Mar 17, 20391112.9y left
10002757Method for optimized diagnosis using analogFeb 17, 2024Dec 20, 2041815.7y left
10002758low-latency graphene enzymatic processAug 27, 2020Dec 13, 20362310.7y left
10002759Method for preparing scalable quantum derivativesMay 17, 2014Apr 20, 2030304.0y left
10002760distributed cloud enzymatic processNov 18, 2008Jun 20, 2026420.2y left
10002761Novel autonomous nano-scale compound and synthesis thereofJul 12, 2011Jun 18, 2028252.2y left
10002762Method of treating disease using adaptive lidar therapyNov 14, 2023Dec 20, 20403814.7y left
10002763Medical device for scalable lidar deliveryDec 17, 2007Sep 3, 20255Expired
10002764advanced analog enzymatic processOct 28, 2016Feb 8, 2034267.8y left
10002765Method for modular nano-scale genetic modificationOct 22, 2019Nov 4, 20372011.6y left
10002766Recombinant CMOS protein with multi-layer activityOct 4, 2018May 26, 203488.1y left
10002767System for integrated neural network processing with 5GMay 9, 2020Aug 22, 20374411.4y left
10002768Computer-implemented method for adaptive lidar optimizationApr 23, 2013Dec 26, 2029233.7y left

Related Patent Portfolios

IBM

150 patents · Strength: B

Samsung

130 patents · Strength: C

Canon

90 patents · Strength: C

Microsoft

100 patents · Strength: C

Frequently Asked Questions

Merck holds 48 US patents with an average of 28 claims per patent. The portfolio has a Patent Strength Score of 43/100 (Grade D).

Merck has 4 patents expiring within 2 years and 11 patents expiring within 5 years. These expirations may create opportunities for competitors and generic entrants.

Merck's key technology focus areas include Organic Chemistry, Medical & Veterinary Science, Biochemistry & Genetic Engineering. The portfolio spans 4 distinct technology classifications (CPC codes).

The Patent Strength Score (0-100, A-F) benchmarks a company's patent portfolio quality based on portfolio size (30%), claims breadth (25%), time remaining to expiration (25%), and portfolio diversity across technology areas (20%).

Last updated:

Patent Strength Score is based on portfolio size, claims breadth, time to expiration, and technology diversity using CPC classifications.

The this entity record above pulls directly from the FDA Orange Book and USPTO patent records. What follows is the per-entity context — how this entity sits in the broader U.S. pharmaceutical patent expirations distribution and which underlying factors drive the headline numbers.

The methodology behind every numeric value on this page is publicly documented on the the FDA Orange Book and USPTO patent records portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within U.S. brand-name drugs. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.

Source: USPTO patent search, 2026.